Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,020 public trials 2,031 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Evaluation Study on Performance of Guided Clinical Pharmacy Consultation in Patients With Multiple Myeloma on First Oral Anticancer Treatment

NCT04309942

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Nîmes University Hospital Nîmes, Occitanie, France

Dijon University Hospital Pharmacy Dijon, France

Perpignan Hospital Center Perpignan, France

View Trial Details

Completed

Role of Osteocytes in Myeloma Bone Disease

NCT02212262

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Indiana University Simon Cancer Center Indianapolis, Indiana, United States

VA Roudebush Medical Center Indianapolis, Indiana, United States

View Trial Details

Completed

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

NCT00004197

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Stanford University Medical Center Stanford, California, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma

NCT00572013

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: University of Nebraska Medical Center, Section of Oncology/Hematology Omaha, Nebraska, United States

View Trial Details

Completed

Feasibility and Accuracy of Core Temperature Measurements Using the Esophageal Temperature Probe Inserted Through the Gastric Lumen of Supraglottic Airway Device in Pediatrics

NCT05705206

Conditions: Body Temperature Changes, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics of DZD8586 in Healthy Adult Participants

NCT05176873

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Frontage Clinical Service 200 Meadowlands Parkway Secaucus, New Jersey, United States

View Trial Details

Completed

Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00007852

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +28 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma

NCT00006695

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: UNMC Eppley Cancer Center at University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation

NCT03873857

Conditions: Cancer, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +15 more
Locations: Oncology Dispensary #2 /ID# 215831 Sochi, Krasnodarskiy Kray, Russia

Moscow State budget healthcare /ID# 212875 Moscow, Russia

Moscow Regional Research and Clinical Institute n.a. Vladimirskiy (MONIKI) /ID# 215830 Moscow, Moscow Oblast, Russia

Academician I.P. Pavlov First St. Petersburg State Medical University /ID# 212368 Saint Petersburg, Sankt-Peterburg, Russia

View all 20 locations

View Trial Details

Completed

An Individualized Physical Activity Program in Patients Over 65 Years With Hematologic Malignancies

NCT04052126

Conditions: Aged, Aged, 80 and Over, Behavior, +19 more
Locations: Centre Léon Bérard Lyon, France

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions